Hepatocyte growth factor and alternative splice variants - expression, regulation and implications in osteogenesis and bone health and repair

References

• Forte G, Minieri M, Cossa P, et al. Hepatocyte growth factor effects on mesenchymal stem cells: proliferation, migration, and differentiation. Stem Cells. 2006;24(1):23–33.
   PubMed Web of Science ®Google Scholar
• Ross J, Gherardi E, Mallorqui-Fernandez N, et al. Protein engineered variants of hepatocyte growth factor/scatter factor promote proliferation of primary human hepatocytes and in rodent liver. Gastroenterology. 2012;142(4):897–906.
   PubMed Web of Science ®Google Scholar
• Grumbles RM, Howell DS, Wenger L, et al. Hepatocyte growth factor and its actions in growth plate chondrocytes. Bone. 1996;19(3):255–261.
   PubMed Web of Science ®Google Scholar
• Stuart KA, Riordan SM, Lidder S, et al. Hepatocyte growth factor/scatter factor-induced intracellular signalling. Int J Exp Pathol. 2000;81(1):17–30.
   PubMed Web of Science ®Google Scholar
• Naldini L, Weidner KM, Vigna E, et al. Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor. EMBO J. 1991;10(10):2867–2878.
   PubMed Web of Science ®Google Scholar
• Gherardi E, Gray J, Stoker M, et al. Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movement. Proc Natl Acad Sci U S A. 1989;86(15):5844–5848.
   PubMed Web of Science ®Google Scholar
• Nakamura T, Sakai K, Matsumoto K. Hepatocyte growth factor twenty years on: much more than a growth factor. J Gastroenterol Hepatol. 2011;26(Suppl 1):188–202.
   PubMed Web of Science ®Google Scholar
• Chan AM, Rubin JS, Bottaro DP, et al. Identification of a competitive HGF antagonist encoded by an alternative transcript. Science. 1991;254(5036):1382–1385.
   PubMed Web of Science ®Google Scholar
• Miyazawa K, Kitamura A, Naka D, et al. An alternatively processed mRNA generated from human hepatocyte growth factor gene. Eur J Biochem. 1991;197(1):15–22.
   PubMedGoogle Scholar
• Athauda G, Cecchi F, Ito T, et al. HGF (hepatocyte growth factor (hepapoietin A; scatter factor)). Atlas Genet Cytogenet Oncol Haematol. 2010;14(10):1008–1025.
   Google Scholar
• Seki T, Hagiya M, Shimonishi M, et al. Organization of the human hepatocyte growth factor-encoding gene. Gene. 1991;102(2):213–219.
   PubMed Web of Science ®Google Scholar
• Stoker M, Gherardi E. Scatter factor and other regulators of cell mobility. Br Med Bull. 1989;45(2):481–491.
   PubMed Web of Science ®Google Scholar
• Naldini L, Vigna E, Bardelli A, et al. Biological activation of pro-HGF (hepatocyte growth factor) by urokinase is controlled by a stoichiometric reaction. J Biol Chem. 1995;270(2):603–611.
   PubMed Web of Science ®Google Scholar
• Cioce V, Csaky KG, Chan AM, et al. Hepatocyte growth factor (HGF)/NK1 is a naturally occurring HGF/scatter factor variant with partial agonist/antagonist activity. J Biol Chem. 1996;271(22):13110–13115.
   PubMed Web of Science ®Google Scholar
• Kuiper J, Van’t Hof A, Otter M, et al. Interaction of mutants of tissue-type plasminogen activator with liver cells: effect of domain deletions. Biochem J. 1996;313(Pt 3):775–780.
   PubMed Web of Science ®Google Scholar
• Miyake M, Saze K, Yaguchi T, et al. Canine hepatocyte growth factor: molecular cloning and characterization of the recombinant protein. Vet Immunol Immunopathol. 2003;95(3–4):135–143.
   PubMed Web of Science ®Google Scholar
• Cai H, Lan X, Li A, et al. SNPs of bovine HGF gene and their association with growth traits in Nanyang cattle. Res Vet Sci. 2013;95(2):483–488.
   PubMed Web of Science ®Google Scholar
• Thery C, Sharpe MJ, Batley SJ, et al. Expression of HGF/SF, HGF1/MSP, and c-met suggests new functions during early chick development. Dev Genet. 1995;17(1):90–101.
   PubMedGoogle Scholar
• Liu Y, Bell AW, Michalopoulos GK, et al. The mouse hepatocyte growth factor-encoding gene: structural organization and evolutionary conservation. Gene. 1994;144(2):179–187.
   PubMed Web of Science ®Google Scholar
• Elsen GE, Choi LY, Prince VE, et al. The autism susceptibility gene met regulates zebrafish cerebellar development and facial motor neuron migration. Dev Biol. 2009;335(1):78–92.
   PubMed Web of Science ®Google Scholar
• Koibuchi N, Kaneda Y, Taniyama Y, et al. Essential role of HGF (hepatocyte growth factor) in blood formation in Xenopus. Blood. 2004;103(9):3320–3325.
   PubMed Web of Science ®Google Scholar
• Takayama H, La Rochelle WJ, Anver M, et al. Scatter factor/hepatocyte growth factor as a regulator of skeletal muscle and neural crest development. Proc Natl Acad Sci U S A. 1996;93(12):5866–5871.
   PubMed Web of Science ®Google Scholar
• Otsuka T, Jakubczak J, Vieira W, et al. Disassociation of met-mediated biological responses in vivo: the natural hepatocyte growth factor/scatter factor splice variant NK2 antagonizes growth but facilitates metastasis. Mol Cell Biol. 2000;20(6):2055–2065.
   PubMed Web of Science ®Google Scholar
• Tolbert WD, Daugherty-Holtrop J, Gherardi E, et al. Structural basis for agonism and antagonism of hepatocyte growth factor. Proc Natl Acad Sci U S A. 2010;107(30):13264–13269.
   PubMed Web of Science ®Google Scholar
• Pediaditakis P, Monga SPS, Mars WM, et al. Differential mitogenic effects of single chain hepatocyte growth factor (HGF)/scatter factor and HGF/NK1 following cleavage by factor Xa. J Biol Chem. 2002;277(16):14109–14115.
   PubMed Web of Science ®Google Scholar
• Basilico C, Arnesano A, Galluzzo M, et al. A high affinity hepatocyte growth factor-binding site in the immunoglobulin-like region of Met. J Biol Chem. 2008;283(30):21267–21277.
   PubMed Web of Science ®Google Scholar
• Montesano R, Soriano JV, Malinda KM, et al. Differential effects of hepatocyte growth factor isoforms on epithelial and endothelial tubulogenesis. Cell Growth Differ. 1998;9(5):355–365.
   PubMedGoogle Scholar
• Hartmann HA, Sun DY. Regional mRNA changes in brain stem motor neurons from patients with amyotrophic lateral sclerosis. Mol Chem Neuropathol. 1992;17(3):249–257.
   PubMedGoogle Scholar
• Ge X, Wang Y, Li Q, et al. NK4 gene therapy inhibits HGF/Met-induced growth of human cholangiocarcinoma cells. Dig Dis Sci. 2013;58(6):1636–1643.
   PubMed Web of Science ®Google Scholar
• Venepalli NK, Goff L. Targeting the HGF-cMET axis in hepatocellular carcinoma. Int J Hepatol. 2013;2013:1–11.
   Google Scholar
• Achim CL, Katyal S, Wiley CA, et al. Expression of HGF and cMet in the developing and adult brain. Brain Res Dev Brain Res. 1997;102(2):299–303.
   PubMedGoogle Scholar
• Grano M, Galimi F, Zambonin G, et al. Hepatocyte growth factor is a coupling factor for osteoclasts and osteoblasts in vitro. Proc Natl Acad Sci U S A. 1996;93(15):7644–7648.
   PubMed Web of Science ®Google Scholar
• Kong-Beltran M, Stamos J, Wickramasinghe D. The sema domain of Met is necessary for receptor dimerization and activation. Cancer Cell. 2004;6(1):75–84.
   PubMed Web of Science ®Google Scholar
• Gherardi E, Youles ME, Miguel RN, et al. Functional map and domain structure of MET, the product of the c-met protooncogene and receptor for hepatocyte growth factor/scatter factor. Proc Natl Acad Sci U S A. 2003;100(21):12039–12044.
   PubMed Web of Science ®Google Scholar
• Comoglio PM. Pathway specificity for Met signalling. Nat Cell Biol. 2001;3(7):E161–E162.
   PubMed Web of Science ®Google Scholar
• Cecchi F, Rabe DC, Bottaro DP. Targeting the HGF/Met signalling pathway in cancer. Eur J Cancer. 2010;46(7):1260–1270.
   PubMed Web of Science ®Google Scholar
• Aenlle KK, Curtis KM, Roos BA, et al. Hepatocyte growth factor and p38 promote osteogenic differentiation of human mesenchymal stem cells. Mol Endocrinol. 2014;28(5):722–730.
   PubMed Web of Science ®Google Scholar
• Chen HT, Tsou HK, Chang CH, et al. Hepatocyte growth factor increases osteopontin expression in human osteoblasts through PI3K, Akt, c-Src, and AP-1 signaling pathway. PLoS One. 2012;7(6):e38378.
   Google Scholar
• Nebreda AR, Porras A. p38 MAP kinases: beyond the stress response. Trends Biochem Sci. 2000;25(6):257–260.
   PubMed Web of Science ®Google Scholar
• Ono K, Han J. The p38 signal transduction pathway: activation and function. Cell Signal. 2000;12(1):1–13.
   PubMed Web of Science ®Google Scholar
• Greenblatt MB, Shim JH, Zou W, et al. The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in mice. J Clin Invest. 2010;120(7):2457–2473.
   PubMed Web of Science ®Google Scholar
• Ortuno MJ, Ruiz-Gaspa S, Rodriguez-Carballo E, et al. p38 regulates expression of osteoblast-specific genes by phosphorylation of osterix. J Biol Chem. 2010;285(42):31985–31994.
   PubMed Web of Science ®Google Scholar
• Ortuno MJ, Susperregui ARG, Artigas N, et al. Osterix induces col1a1 gene expression through binding to Sp1 sites in the bone enhancer and proximal promoter regions. Bone. 2013;52(2):548–556.
   PubMed Web of Science ®Google Scholar
• Lee KH, Kim JR. Kiss-1 suppresses MMP-9 expression by activating p38 MAP kinase in human stomach cancer. Oncol Res. 2009;18(2–3):107–116.
   PubMed Web of Science ®Google Scholar
• Limaye PB, Bowen WC, Orr AV, et al. Mechanisms of hepatocyte growth factor-mediated and epidermal growth factor-mediated signaling in transdifferentiation of rat hepatocytes to biliary epithelium. Hepatology. 2008;47(5):1702–1713.
   PubMed Web of Science ®Google Scholar
• Fresno Vara JA, Casado E, de Castro J, et al. PI3K/Akt signalling pathway and cancer. Cancer Treat Rev. 2004;30(2):193–204.
   PubMed Web of Science ®Google Scholar
• Xiao GH, Jeffers M, Bellacosa A, et al. Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways. Proc Natl Acad Sci U S A. 2001;98(1):247–252.
   PubMed Web of Science ®Google Scholar
• Chen K, Perez-Stable C, D’Ippolito G, et al. Human bone marrow-derived stem cell proliferation is inhibited by hepatocyte growth factor via increasing the cell cycle inhibitors p53, p21 and p27. Bone. 2011;49(6):1194–1204.
   PubMed Web of Science ®Google Scholar
• Nardone V, D’Asta F, Brandi ML. Pharmacological management of osteogenesis. Clinics (Sao Paulo). 2014;69(6):438–446.
   PubMed Web of Science ®Google Scholar
• Boyce BF, Xiu Y, Li J, et al. NF-kappaB-mediated regulation of osteoclastogenesis. Endocrinol Metab (Seoul). 2015;30(1):35–44.
   PubMedGoogle Scholar
• Hsu H, Lacey DL, Dunstan CR, et al. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci U S A. 1999;96(7):3540–3545.
   PubMed Web of Science ®Google Scholar
• Boyce BF, Xing L. Biology of RANK, RANKL, and osteoprotegerin. Arthritis Res Ther. 2007;9(Suppl 1):S1.
   PubMed Web of Science ®Google Scholar
• Teitelbaum SL. Bone resorption by osteoclasts. Science. 2000;289(5484):1504–1508.
   PubMed Web of Science ®Google Scholar
• Hofbauer LC, Schoppet M. Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. JAMA. 2004;292(4):490–495.
   PubMed Web of Science ®Google Scholar
• Proto JD, Tang Y, Lu A, et al. NF-kappaB inhibition reveals a novel role for HGF during skeletal muscle repair. Cell Death Dis. 2015;6:e1730.
   Web of Science ®Google Scholar
• D’Ippolito G, Schiller PC, Perez-stable C, et al. Cooperative actions of hepatocyte growth factor and 1,25-dihydroxyvitamin D3 in osteoblastic differentiation of human vertebral bone marrow stromal cells. Bone. 2002;31(2):269–275.
   PubMed Web of Science ®Google Scholar
• Matsumoto K, Tajima H, Nakamura T. Hepatocyte growth factor is a potent stimulator of human melanocyte DNA synthesis and growth. Biochem Biophys Res Commun. 1991;176(1):45–51.
   PubMed Web of Science ®Google Scholar
• Yin J, Lee JH, Zhang J, et al. Regulation of hepatocyte growth factor expression by NF-κB and PPARγ in adipose tissue. Am J Physiol Endocrinol Metab. 2014;306(8):E929–E936.
   Google Scholar
• Matsubara H, Tsuchiya H, Watanabe K, et al. Percutaneous nonviral delivery of hepatocyte growth factor in an osteotomy gap promotes bone repair in rabbits: a preliminary study. Clin Orthop Relat Res. 2008;466(12):2962–2972.
   PubMed Web of Science ®Google Scholar
• Goshima K, Nakase J, Xu Q, et al. Repair of segmental bone defects in rabbit tibia promoted by a complex of β-tricalcium phosphate and hepatocyte growth factor. J Orthop Sci. 2012;17(5):639–648.
   PubMed Web of Science ®Google Scholar
• Wen Q, Jin D, Zhou CY, et al. HGF-transgenic MSCs can improve the effects of tissue self-repair in a rabbit model of traumatic osteonecrosis of the femoral head. PLoS One. 2012;7(5):e37503.
   Google Scholar
• Standal T, Abildgaard N, Fagerli UM, et al. HGF inhibits BMP-induced osteoblastogenesis: possible implications for the bone disease of multiple myeloma. Blood. 2007;109(7):3024–3030.
   PubMed Web of Science ®Google Scholar
• Abed E, Bouvard B, Martineau X, et al. Elevated hepatocyte growth factor levels in osteoarthritis osteoblasts contribute to their altered response to bone morphogenetic protein-2 and reduced mineralization capacity. Bone. 2015;75:111–119.
   PubMed Web of Science ®Google Scholar
• Walker N, Kahamba T, Woudberg N, et al. Dose-dependent modulation of myogenesis by HGF: implications for c-Met expression and downstream signalling pathways. Growth Factors. 2015;33(3):229–241.
   PubMed Web of Science ®Google Scholar
• Shibasaki S, Kitano S, Karasaki M, et al. Blocking c-Met signaling enhances bone morphogenetic protein-2-induced osteoblast differentiation. FEBS Open Bio. 2015;5:341–347.
   PubMed Web of Science ®Google Scholar
• Kawasaki T, Niki Y, Miyamoto T, et al. The effect of timing in the administration of hepatocyte growth factor to modulate BMP-2-induced osteoblast differentiation. Biomaterials. 2010;31(6):1191–1198.
   PubMed Web of Science ®Google Scholar
• Peruzzi B, Bottaro DP. Targeting the c-Met signaling pathway in cancer. Clin Cancer Res. 2006;12(12):3657–3660.
   PubMed Web of Science ®Google Scholar
• Zenali M, deKay J, Liu Z, et al. Retrospective review of MET gene mutations. Oncoscience. 2015;2(5):533–541.
   PubMedGoogle Scholar
• Cecchi F, Rabe DC, Bottaro DP. Targeting the HGF/Met signaling pathway in cancer therapy. Expert Opin Ther Targets. 2012;16(6):553–572.
   PubMed Web of Science ®Google Scholar
• Sugiura T, Takahashi S, Sano K, et al. Pharmacokinetic modeling of hepatocyte growth factor in experimental animals and humans. J Pharm Sci. 2013;102(1):237–249.
   PubMed Web of Science ®Google Scholar
• Cui S, Guo L, Li X, et al. Clinical safety and preliminary efficacy of plasmid pUDK-HGF expressing human hepatocyte growth factor (HGF) in patients with critical limb ischemia. Eur J Vasc Endovasc Surg. 2015;50(4):494–501.
   PubMed Web of Science ®Google Scholar
• Appasamy R, Tanabe M, Murase N, et al. Hepatocyte growth factor, blood clearance, organ uptake, and biliary excretion in normal and partially hepatectomized rats. Lab Invest. 1993;68(3):270–276.
   PubMed Web of Science ®Google Scholar
• Zioncheck TF, Richardson L, DeGuzman GG, et al. The pharmacokinetics, tissue localization, and metabolic processing of recombinant human hepatocyte growth factor after intravenous administration in rats. Endocrinology. 1994;134(4):1879–1887.
   PubMed Web of Science ®Google Scholar
• Kaga T, Kawano H, Sakaguchi M, et al. Hepatocyte growth factor stimulated angiogenesis without inflammation: differential actions between hepatocyte growth factor, vascular endothelial growth factor and basic fibroblast growth factor. Vascul Pharmacol. 2012;57(1):3–9.
   PubMed Web of Science ®Google Scholar
• Kitamura K, Fujiyoshi K, Yamane J, et al. Human hepatocyte growth factor promotes functional recovery in primates after spinal cord injury. PLoS One. 2011;6(11):e27706.
   PubMed Web of Science ®Google Scholar
• Liu P, Guo L, Huang L, et al. Effect of semisynthetic extracellular matrix-like hydrogel containing hepatocyte growth factor on repair of femoral neck defect in rabbits. Int J Clin Exp Med. 2015;8(5):7374–7380.
   PubMed Web of Science ®Google Scholar
• Chiang CH, Wu WW, Li HY, et al. Enhanced antioxidant capacity of dental pulp-derived iPSC-differentiated hepatocytes and liver regeneration by injectable HGF-releasing hydrogel in fulminant hepatic failure. Cell Transplant. 2015;24(3):541–559.
   PubMed Web of Science ®Google Scholar
• Chaparro RE, Izutsu M, Sasaki T, et al. Sustained functional improvement by hepatocyte growth factor-like small molecule BB3 after focal cerebral ischemia in rats and mice. J Cereb Blood Flow Metab. 2015;35(6):1044–1053.
   PubMed Web of Science ®Google Scholar
• Sun D, Yuan D, Zhang X. A new hypothesis on the mechanism of atrophic non-union. Med Hypotheses. 2011;77(1):69–70.
   PubMed Web of Science ®Google Scholar
• Vogel S, Trapp T, Borger V, et al. Hepatocyte growth factor-mediated attraction of mesenchymal stem cells for apoptotic neuronal and cardiomyocytic cells. Cell Mol Life Sci. 2010;67(2):295–303.
   PubMed Web of Science ®Google Scholar
• Shigematsu H, Yasuda K, Sasajima T, et al. Transfection of human HGF plasmid DNA improves limb salvage in Buerger’s disease patients with critical limb ischemia. Int Angiol. 2011;30(2):140–149.
   PubMed Web of Science ®Google Scholar
• Powell RJ, Simons M, Mendelsohn FO, et al. Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia. Circulation. 2008;118(1):58–65.
   PubMed Web of Science ®Google Scholar
• Shigematsu H, Yasuda K, Iwai T, et al. Randomized, double-blind, placebo-controlled clinical trial of hepatocyte growth factor plasmid for critical limb ischemia. Gene Ther. 2010;17(9):1152–1161.
   PubMed Web of Science ®Google Scholar
• Yang J, Chen S, Huang L, et al. Sustained expression of naked plasmid DNA encoding hepatocyte growth factor in mice promotes liver and overall body growth. Hepatology. 2001;33(4):848–859.
   PubMed Web of Science ®Google Scholar
• Morishita R, Makino H, Aoki M, et al. Phase I/IIa clinical trial of therapeutic angiogenesis using hepatocyte growth factor gene transfer to treat critical limb ischemia. Arterioscler Thromb Vasc Biol. 2011;31(3):713–720.
   PubMed Web of Science ®Google Scholar
• Jones DS 2nd, Tsai PC, Cochran JR. Engineering hepatocyte growth factor fragments with high stability and activity as Met receptor agonists and antagonists. Proc Natl Acad Sci U S A. 2011;108(32):13035–13040.
   PubMed Web of Science ®Google Scholar